Western blot results showed that the expression levels of CHOP, GRP78 and Caspase-12 were significantly increased by 1.3-fold, 2.2-fold and 1.3-fold of control, respectively, when the MetS group was compared with the control group. The gene discussed is CASP12; the disease is metabolic syndrome.